Showing 8 of 8 recruiting trials for “Gaucher disease”
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
👨⚕️ Zhang Huiwen, Dr., Xinhua Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Mar 2023View details ↗
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
👨⚕️ Sarah Neuhaus, DO, Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company📍 8 sites📅 Started Dec 2022View details ↗
RecruitingNCT03190837 ↗
A Long-term Follow-up Study of Gaucher Disease
Gaucher Disease Outcome Survey (GOS)
Genetic Studies of Lysosomal Storage Disorders
👨⚕️ Ellen Sidransky, M.D., National Human Genome Research Institute (NHGRI)📍 1 site📅 Started Mar 1995View details ↗
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →